Skip to main content
. 2022 Nov 19;22:2127. doi: 10.1186/s12889-022-14590-y

Table 6.

Change in secondary outcomes (laboratory variables and weight) from baseline to 12-month follow-up

Intervention attributable difference Mean (95% CI) p value Intervention attributable difference (IG-CG) (% (95% CI))
Adjusted for age, sex, centre, dietary habits stage motivation and change in physical activity and smoking cessation
p value
Outcome measure EIRA Intervention (n = 1481) Usual care (n = 1581)
Baseline After 12 months Difference Baseline After 12 months Difference
Total cholesterol (mg/dL) 206.6 (3.8) 203.7 (20.0) -2.9 (20.8) 206.5 (4.2) 205.8 (20.0) -0.7 (21.2) -2.2 (-10.4 to 6.1) 0.603 -1.2 (-4.6 to -2.3) 0.515
LDL-cholesterol (mg/dL) 127.3 (4.8) 123.1 (21.4) -4.2 (23.0) 127.2 (4.9) 125.6 (20.7) -1.6 (22.2) -2.6 (-10.8 to 5.6) 0.531 -1.7 (-5.7 to 2.3) 0.395
HDL-cholesterol (mg/dL) 53.0 (1.1) 54.0 (5.4) 1.0 (5.7) 53.7 (1.4) 54.6 (5.3) 0.9 (5.5) 0.0 (-2.8 to 2.8) 0.990 0.1 (-1.1 to 1.3) 0.905
Triglycerides (mg/dL) 148.2 (17.2) 187.7 (49.3) 39.5 (49.4) 146.5 (19.4) 178.9 (47.2) 32.4 (48.5) 7.1 (-17.2 to 31.4) 0.563 5.7 (-7.0 to 18.3) 0.380
Glycated haemoglobin (%) 7.5 (0.4) 7.4 (0.8) -0.1 (0.8) 7.5 (0.4) 7.4 (0.8) -0.0 (0.8) -0.1 (-0.6 to 0.4) 0.771 -0.1 (-0.4 to 0.3) 0.676
Systolic blood pressure (mmHg) 133.5 (1.4) 131.6 (6.9) -1.9 (7.3) 131.9 (0.7) 132.1 (5.7) 0.2 (5.8) -2.1 (-6.0 to 1.8) 0.286 -2.4 (-4.3 to -0.5) 0.014
Diastolic blood pressure (mmHg) 82.5 (0.7) 81.9 (3.9) -0.6 (3.9) 80.5 (0.4) 80.9 (3.1) 0.4 (3.1) -1.0 (-3.3 to 1.4) 0.414 -1.2 (-2.6 to 0.1) 0.073
Weight (kg) 82.3 (0.6) 82.1 (5.9) -0.2 (6.0) 78.8 (0.4) 79.1 (4.8) 0.3 (4.8) -0.5 (-4.0 to 2.9) 0.764 -0.4 (-2.5 to 1.7) 0.711

Data expressed as mean (standard error)